IMA
NASDAQ · Pharmaceuticals
Imagenebio Inc
$5.83
-0.17 (-2.83%)
Open$5.86
Previous Close$6.00
Day High$5.91
Day Low$5.73
52W High$18.00
52W Low$3.94
Volume—
Avg Volume13.6K
Market Cap70.86M
P/E Ratio—
EPS$-5.40
SectorPharmaceuticals
Analyst Ratings
Buy
7 analysts
Price Target
+106.2% upside
Current
$5.83
$5.83
Target
$12.02
$12.02
$8.98
$12.02 avg
$15.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.06M | 5.54M | 44.29M |
| Net Income | -116,763,222 | -282,948,033 | 4.55M |
| Profit Margin | -5,668.6% | -5,385.2% | 10.3% |
| EBITDA | -123,722,461 | -316,468,330 | 9.89M |
| Free Cash Flow | — | — | 3.33M |
| Rev Growth | -62.9% | -62.9% | -0.9% |
| Debt/Equity | — | — | 0.50 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |